We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

185 hedge funds and large institutions have $1.02B invested in Arcus Biosciences in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 68 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $14.5M | Put options by funds: $7.25M

8% more capital invested

Capital invested by funds: $948M → $1.02B (+$74.9M)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0.64% more ownership

Funds ownership: 70.89% → 71.53% (+0.64%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 68

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
2.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
62
Reduced
68
Closed
25
Calls
$14.5M
Puts
$7.25M
Net Calls
+$7.26M
Net Calls Change
+$510K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$12.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$12.2M
3
BlackRock
BlackRock
New York
+$6.65M
4
SCM
Suvretta Capital Management
New York
+$5.76M
5
LGM
Logos Global Management
California
+$5.19M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$25.2M
2
American Century Companies
American Century Companies
Missouri
-$6.49M
3
N
Nuveen
North Carolina
-$5.28M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$4.44M
5
Barclays
Barclays
United Kingdom
-$4.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
OPERF
126
Oregon Public Employees Retirement Fund
Oregon
$301K -$2.03K -127 -0.8%
FRM
127
Fox Run Management
Connecticut
$294K -$70.5K -4,408 -22%
State Board of Administration of Florida Retirement System
128
State Board of Administration of Florida Retirement System
Florida
$288K – – –
PP
129
PDT Partners
New York
$286K +$239K +14,974 New
ASRS
130
Arizona State Retirement System
Arizona
$259K +$128 +8 +0.1%
EFM
131
E Fund Management
China
$258K -$24.6K -1,537 -10%
CIC
132
Cornercap Investment Counsel
Georgia
$244K – – –
Handelsbanken Fonder
133
Handelsbanken Fonder
Sweden
$244K +$205K +12,800 New
Allspring Global Investments
134
Allspring Global Investments
North Carolina
$226K +$40.2K +2,516 +27%
COPPSERS
135
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$222K -$387K -24,233 -68%
Teacher Retirement System of Texas
136
Teacher Retirement System of Texas
Texas
$213K -$37.4K -2,341 -17%
NIM
137
NEOS Investment Management
Connecticut
$213K +$178K +11,141 New
AQR Capital Management
138
AQR Capital Management
Connecticut
$209K +$175K +10,947 New
Ohio Public Employees Retirement System (OPERS)
139
Ohio Public Employees Retirement System (OPERS)
Ohio
$206K +$140K +8,787 +439%
Capstone Investment Advisors
140
Capstone Investment Advisors
New York
$203K +$170K +10,643 New
ProShare Advisors
141
ProShare Advisors
Maryland
$193K +$161K +10,100 New
ECM
142
Everence Capital Management
Indiana
$192K – – –
US Bancorp
143
US Bancorp
Minnesota
$165K +$108K +6,751 +353%
SO
144
STRS Ohio
Ohio
$158K +$94.3K +5,900 +246%
BC
145
BIT Capital
Germany
$134K +$112K +7,000 New
ETC
146
Exchange Traded Concepts
Oklahoma
$130K +$27.6K +1,729 +34%
Amundi
147
Amundi
France
$125K – – –
VEA
148
Virtus ETF Advisers
New York
$100K +$3.34K +209 +4%
AIP
149
Ameritas Investment Partners
Nebraska
$100K – – –
Royal Bank of Canada
150
Royal Bank of Canada
Ontario, Canada
$100K +$83.3K +5,211 +28,950%
4 5
6
7 8

RCUS Hedge Fund Activity: Q4 2023 in Review

185 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q4 2023, worth a combined $1.02B — up 7.9% from $948M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 25 closed out — a net gain of 1 holder — while 62 added to existing stakes and 68 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $12.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $25.2M sold.

  • 185 institutional investors held Arcus Biosciences (RCUS) as of Q4 2023, down from 187 in Q3 2023.
  • Funds reported $1.02B of Arcus Biosciences stock for Q4 2023, up 7.9% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q4 2023 and 25 closed out, a net change of +1 holder.
  • The largest Arcus Biosciences buyer in Q4 2023 was Morgan Stanley, an estimated $12.7M added.
  • The largest Arcus Biosciences seller in Q4 2023 was PFM Health Sciences, an estimated $25.2M sold.

Based on aggregated 13F filings for Q4 2023.